LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
-3.4%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.61B
AUM Growth
+$1.61B
(-18%)
Cap. Flow
-$234M
Cap. Flow
% of AUM
-14.54%
Top 10 Holdings %
Top 10 Hldgs %
19.7%
Holding
510
New
10
Increased
104
Reduced
55
Closed
293
Top Buys
| 1 |
CIXX
CI Financial Corp.
CIXX
|
$13.2M |
| 2 |
Pinduoduo
PDD
|
$12.2M |
| 3 |
Futu Holdings
FUTU
|
$12.1M |
| 4 |
Huazhu Hotels Group
HTHT
|
$8.49M |
| 5 |
Fate Therapeutics
FATE
|
$7.52M |
Top Sells
| 1 |
InMode
INMD
|
$23.9M |
| 2 |
QuidelOrtho
QDEL
|
$14.1M |
| 3 |
Halozyme
HALO
|
$13.6M |
| 4 |
Trip.com Group
TCOM
|
$13M |
| 5 |
Amazon
AMZN
|
$12.8M |
Sector Composition
| 1 | Healthcare | 53.98% |
| 2 | Consumer Discretionary | 13.16% |
| 3 | Financials | 11.73% |
| 4 | Technology | 5.09% |
| 5 | Industrials | 2.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Pool Corp
POOL
$11.4B
| $13.4M | 0.83% |
30,774
+223
| +0.7% | +$96.8K |
|
|
CIXX
52
DELISTED
CI Financial Corp.
CIXX
| $13.2M | 0.82% |
+652,809
| New | +$13.2M |
|
|
GTHX
53
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $12.9M | 0.8% |
961,139
+145,823
| +18% | +$1.96M |
|
54
Sangamo Therapeutics
SGMO
$161M
| $12.7M | 0.79% |
1,409,736
+202,795
| +17% | +$1.83M |
|
55
Quanterix
QTRX
$202M
| $12.3M | 0.76% |
246,304
+22,839
| +10% | +$1.14M |
|
56
Sea Limited
SE
$107B
| $12.2M | 0.76% |
39,499
+13,306
| +51% | +$4.1M |
|
|
57
Futu Holdings
FUTU
$27B
| $12.1M | 0.75% |
+135,132
| New | +$12.1M |
|
|
RCM
58
DELISTED
R1 RCM Inc. Common Stock
RCM
| $11.6M | 0.72% |
528,926
+135,897
| +35% | +$2.99M |
|
59
Masimo
MASI
$7.43B
| $10.8M | 0.67% |
40,000
| – | – |
|
60
Novavax
NVAX
$1.2B
| $10.7M | 0.67% |
51,931
-57,492
| -53% | -$11.9M |
|
61
Y-mAbs Therapeutics
YMAB
$390M
| $10.1M | 0.63% |
352,839
+32,807
| +10% | +$936K |
|
|
TRHC
62
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $9.47M | 0.59% |
361,187
-82,556
| -19% | -$2.16M |
|
63
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$2.31B
| $9.18M | 0.57% |
258,240
+31,600
| +14% | +$1.12M |
|
64
Sutro Biopharma
STRO
$85.6M
| $9.14M | 0.57% |
483,763
+55,924
| +13% | +$1.06M |
|
|
OZON
65
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
| $9.1M | 0.57% |
183,600
+8,000
| +5% | +$397K |
|
66
Karyopharm Therapeutics
KPTI
$61.4M
| $8.83M | 0.55% |
1,517,804
+141,432
| +10% | +$823K |
|
67
Editas Medicine
EDIT
$225M
| $8.57M | 0.53% |
208,504
-94,629
| -31% | -$3.89M |
|
|
68
Huazhu Hotels Group
HTHT
$11.2B
| $8.49M | 0.53% |
+188,228
| New | +$8.49M |
|
69
XP
XP
$9.38B
| $8.17M | 0.51% |
206,900
| – | – |
|
70
SPDR S&P 500 ETF Trust
SPY
$656B
| $7.78M | 0.48% |
19,429
-1,177
| -6% | -$471K |
|
|
71
Fate Therapeutics
FATE
$115M
| $7.52M | 0.47% |
+126,910
| New | +$7.52M |
|
72
Meta Platforms (Facebook)
META
$1.85T
| $7.34M | 0.46% |
23,305
+3,799
| +19% | +$1.2M |
|
73
Apellis Pharmaceuticals
APLS
$3.51B
| $6.81M | 0.42% |
206,746
-188,287
| -48% | -$6.21M |
|
74
iShares Core MSCI Emerging Markets ETF
IEMG
$102B
| $6.36M | 0.4% |
110,410
+6,072
| +6% | +$350K |
|
75
iRhythm Technologies
IRTC
$5.67B
| $5.84M | 0.36% |
99,772
+21,573
| +28% | +$1.26M |
|